Home
Dashboard
Curated content
Themes
Innovations
Key Innovators
Key Innovators - Universities
European Innovation Council
Funding rounds
Companies
Corporates
Investors
Jobs
Support Organisations
Events
Investment heatmap
Matching tool
Companies
Zoticon BioVentures
Save
Zoticon BioVentures
Zoticon has invested over $100 million to date in promising phase III therapeutics including two oncology products and a cardiovascular.
Bet Shemesh Jerusalem District (HQ)
http://zoticon.com
B2B
manufacturing
subscription
health
outside tech
cardiology
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
Related Content
Recent News about Zoticon BioVentures
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access
Investments by Zoticon BioVentures
Edit
Sopherion Therapeutics